Methicillin-Resistant Staphylococcus aureus Control in the 21st Century: Laboratory Involvement Affecting Disease Impact and Economic Benefit from Large Population Studies

Author:

Peterson Lance R.1234,Schora Donna M.3

Affiliation:

1. Departments of Medicine and Pathology, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA

2. Department of Medicine, Division of Infectious Diseases, NorthShore University HealthSystem, Evanston, Illinois, USA

3. Department of Pathology and Laboratory Medicine, Division of Microbiology, NorthShore University HealthSystem, Evanston, Illinois, USA

4. Department of Infection Control, NorthShore University HealthSystem, Evanston, Illinois, USA

Abstract

ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) infection is a global health care problem. Large studies (e.g., >25,000 patients) show that active surveillance testing (AST) followed by contact precautions for positive patients is an effective approach for MRSA disease control. With this approach, the clinical laboratory will be asked to select what AST method(s) to use and to provide data monitoring outcomes of the infection prevention interventions. This minireview summarizes evidence for MRSA disease control, reviews the involvement of the laboratory, and provides examples of how to undertake a program cost analysis. Health care organizations with total MRSA clinical infections of >0.3/1,000 patient days or bloodstream infections of >0.03/1,000 patient days should implement a MRSA control plan.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference34 articles.

1. Personal Reflections on Nosocomial Staphylococcal Infections and the Development of Hospital Surveillance

2. Centers for Disease Control and Prevention. 2016. Methicillin-resistant Staphylococcus aureus (MRSA) infections. http://www.cdc.gov/mrsa/tracking/. Accessed 10 March 2016.

3. Centers for Disease Control and Prevention. 2012. Active bacterial core surveillance (ABCs) report emerging infections program network methicillin-resistant Staphylococcus aureus 2012. http://www.cdc.gov/abcs/reports-findings/survreports/mrsa12.pdf.

4. Joint Commission Resources. 2016. Standard IC.01.02.01. In 2016 laboratory accreditation standards. Joint Commission Resources, Oakbrook Terrace, IL.

5. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3